Skip to main content
The BMJ logoLink to The BMJ
. 1994 Nov 19;309(6965):1337–1338. doi: 10.1136/bmj.309.6965.1337

Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis.

E A Murphy 1, A L Bell 1, J Wojtulewski 1, M Brzeski 1, R Madhok 1, H A Capell 1
PMCID: PMC2541893  PMID: 7866082

Full text

PDF
1337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gudbjörnsson B., Hällgren R., Wide L., Birgegård G. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis. 1992 Jun;51(6):747–752. doi: 10.1136/ard.51.6.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Pincus T., Olsen N. J., Russell I. J., Wolfe F., Harris E. R., Schnitzer T. J., Boccagno J. A., Krantz S. B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 1990 Aug;89(2):161–168. doi: 10.1016/0002-9343(90)90294-n. [DOI] [PubMed] [Google Scholar]
  3. Takashina N., Kondo H., Kashiwazaki S. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol. 1990 Jul;17(7):885–887. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES